Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-11 4:00 pm Purchase | 2025-12-08 | 13G | Crescent Biopharma, Inc. CBIO | ForGrowth III PA B.V. | 1,677,852 6.100% | 1,677,852 (New Position) | Filing History |
| 2025-11-14 09:46 am Sale | 2025-10-16 | 13G | Astria Therapeutics, Inc. ATXS | ForGrowth III PA B.V. | 0 0.000% | -3,822,537 (Position Closed) | Filing History |
| 2025-10-29 7:51 pm Purchase | 2025-10-23 | 13G | RAPT Therapeutics, Inc. RAPT | ForGrowth III PA B.V. | 1,833,333 7.400% | 1,833,333 (New Position) | Filing History |
| 2025-09-23 4:00 pm Purchase | 2025-09-18 | 13G | Vor Biopharma Inc. VOR | ForGrowth III PA B.V. | 7,000,000 9.990% | 7,000,000 (New Position) | Filing History |
| 2025-05-15 08:45 am Purchase | 2025-03-31 | 13G | Astria Therapeutics, Inc. ATXS | ForGrowth III PA B.V. | 3,822,537 6.800% | 950,000 (+33.07%) | Filing History |
| 2025-01-07 07:45 am Purchase | 2024-12-30 | 13G | Astria Therapeutics, Inc. ATXS | ForGrowth III PA B.V. | 2,872,537 5.100% | 2,872,537 (New Position) | Filing History |